In this episode of The Better Life, Dr. Pinkston sits down with Ray Solano, pharmacist and founder of PD Labs, to expose the massive barrier to entry in the traditional pharmaceutical industry and explore why highly effective treatments often get buried by "Big Pharma."
If a medication can’t guarantee a billion-dollar market, major pharmaceutical companies won’t touch it—even if it could save or drastically improve lives. Dr. Pinkston and Ray break down how the current clinical trial system is flawed, the massive price discrepancies between commercial biologics and tailored solutions, and why looking at global case studies and cellular science is more reliable than the corporate "show me the science" narrative.
Key Topics Covered in This Episode:
The Billion-Dollar Drug Hurdle: Why life-changing formulas for conditions like Peyronie’s disease and localized inflammation are ignored by major drug companies.
The $22,000 Contrast: Dr. Pinkston shares a shocking look at the monthly cost of commercial autoimmune biologics versus affordable, root-cause healing.
The Power of Transdermal Peptides: How PD Labs successfully formulated BPC-157 as a topical application to provide instant relief for tendonitis and muscle inflammation.
Demystifying Generics & Compounding: The hidden truth about bioequivalence versus therapeutic equivalence in generic medications.
Alternative Therapies That Work: Insights into the neurological benefits of Leucovorin, using Ivermectin in combination oncology therapies, and the anti-Aging benefits of topical Glutathione and GHK Copper for summer skincare.
The Telemedicine Trend: A warning on the safety risks of modern online prescription platforms that over-medicate without standard clinical overviews.
Visit PD Labs: pdlabsrx.com
Call PD Labs Pharmacy: 888-909-0110 (For clinical overviews, nutritional workups, and custom compounding programs)
Watch More Episodes: Find all previous shows from the last four years at drpbetterlife.com
